BACKGROUND
COVID-19 Pneumonia was initially described in China and quickly became a pandemic with high morbidity and significant social and financial loss. (1) More than 70% of COVID-19 infections are mild, 20% require hospitalization, and 5% need intensive therapy. (2, 3) Post-organ transplant patients are at a higher risk of developing COVID-19 infection due to immunosuppression. These patients are also at a higher risk for severe COVID-19 infection and its complications than the general population. (4, 5) Cardiac transplant recipients’ are at a higher risk of developing COVID-19 infection due to having multiple comorbidities and receiving immunosuppression therapy. (6)
We are reporting a case of COVID-19 infection in cardiac transplant recipient patients as well as reviewing the available literature.